CoorsTek Medical, LLC, a company affiliated with CoorsTek, Inc. of Fort Worth, Texas, has acquired medical device manufacturer Nanosurfaces Industries Sri. (NSI) of Bologna, Italy. According to the press release, after a brief transition period, the Nanosurfaces Industries name will be retired and the Bologna operations will fully adopt the CoorsTek Medical brand.
CoorsTek Medical Acquires Italian Ortho Firm

NSI was the manufacturing division of SAMO spa, one of Europe’s longest-standing orthopedic original equipment manufacturers (OEMs). As part of the agreement, CoorsTek Medical will add the newly restructured SAMO and SAMO Italia to the roster of medical device OEMs for whom it manufactures.
CoorsTek Medical officials say that the acquisition establishes a strong European presence for the company with a 25, 000 sq. ft. manufacturing facility in Bologna. Additional synergies with CoorsTek Medical will include the expansion of that firm’s manufacturing competencies through Bologna’s surface modification technology capabilities.
”CoorsTek is a widely known and well respected brand in Europe, providing strong support for CoorsTek Medical’s expansion in the European medical device sector, ” said CEO Jonathan Coors. “CoorsTek Medical’s acquisition of NSI gives us direct access to a large and growing European medical device marketplace in addition to increasing CoorsTek Medical’s manufacturing capacity, expertise, and capabilities. They are a great fit for CoorsTek and CoorsTek Medical.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.